Anxiety Disorders Recruiting Phase 4 Trials for Paroxetine (DB00715)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02022709Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD PatientsTreatment